Blood processor
Latest Bristol-Myers Squibb Company Patents:
- TREATMENT OF RENAL CELL CARCINOMA
- METHODS OF TREATING A TUMOR USING AN ANTI-PD-1 ANTIBODY
- Crystalline form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-D3) pyridazine-3-carboxamide
- Galectin-3 inhibitors
- TREATMENT OF HODGKIN LYMPHOMA USING AN ANTI-PD-1 ANTIBODY
Description
FIG. 1 is a front view of the blood processor of the present invention;
FIG. 2 is a side view of the blood processor of the present invention;
FIG. 3 is a top view of the blood processor of the present invention;
FIG. 4 is a front perspective view of the blood processor of the present invention;
FIG. 5 is a rear perspective view of the blood processor of the present invention;
FIG. 6 is a bottom view of the blood processor of the present invention; and,
FIG. 7 is a rear view of the blood processor of the present invention.
Referenced Cited
Patent History
Patent number: D396289
Type: Grant
Filed: Apr 28, 1997
Date of Patent: Jul 21, 1998
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventor: Steve McGugan (Copenhagen)
Primary Examiner: Stella Reid
Attorneys: Theodore R. Furman, Jr., Stuart E. Krieger, John M. Kilcoyne
Application Number: 0/69,559
Type: Grant
Filed: Apr 28, 1997
Date of Patent: Jul 21, 1998
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventor: Steve McGugan (Copenhagen)
Primary Examiner: Stella Reid
Attorneys: Theodore R. Furman, Jr., Stuart E. Krieger, John M. Kilcoyne
Application Number: 0/69,559
Classifications
Current U.S. Class:
Hematological Or Intravenous Treatment (41) (D24/169)
International Classification: 2401;
International Classification: 2401;